Navigation Links
Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
Date:4/3/2008

WAYNE, Pa., April 3, 2008 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq: ESMC) today announced that its Sonomed, Inc. subsidiary received approval from the State Food and Drug Administration within the People's Republic of China to market the PacScan(R) and E/Z-Scan(R) series of products in that country. The PacScan(R) series consists of A-scans, pachymeters, and combination systems used in both cataract and refractive surgery. The E/Z- Scan(R) series consists of both B-scan and A/B-scan systems for enhanced diagnostic capabilities. Both systems are widely marketed internationally and have become some of the best-selling ophthalmic biometry and ultrasound imaging systems in the world.

The company has immediate plans to market both series of instruments through its two existing distributors in mainland China, the Hwa-In Group and Shenzhen K&K, and also plans to increase its direct support network to assist distributors, attend regional meetings, and provide training as needed.

"Sonomed was well known and respected in the People's Republic of China prior to Medical Device Registration requirements and we look forward to re- introducing our latest line of ophthalmic ultrasound products with similar success," said Barry Durante, President of Sonomed, Inc. "These instruments will provide physicians the opportunity to offer a safe and accurate ultrasound examination to improve their diagnostic capability and patient surgical outcomes."

Sonomed, Inc. is a diagnostic ultrasound company specializing in the design, manufacture and distribution of instruments for ophthalmology. Sonomed is focused on providing quality instrumentation for ophthalmic physicians' offices, clinics and hospitals.

The PacScan(R) and E/
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Escalon(R) Announces Executive Promotions
2. Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System
3. Escalon(R) Reports First Quarter Fiscal 2008 Results
4. Escalon(R) Reports Financial Results for 2007 Fiscal Year
5. NUCRYST Announces Senior Management Change
6. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
7. Medical Records Institute Announces New TEPR Award for EMRs Best Meeting Medicolegal Requirements
8. East Ridge Retirement Village Announces Enhancement Plan
9. QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index
10. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
11. Selective Insurance Group Announces Officer Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Ethiopia (PRWEB) , ... July 28, 2015 , ... ... during U.S. President Barack Obama’s visit to Ethiopia to learn more about the ... the Future Initiative . This initiative focuses on accelerating agricultural development as an ...
(Date:7/28/2015)... ... July 28, 2015 , ... opaJUMP! and O-PA! Performance ... health outcomes associated with its training methods. This company is also the first ... study, conducted in early 2015, training yielded an average 80% improvement in functional ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic ... returns skin to a smooth state, and reduces the appearance of fine lines and ... only FDA-approved injectable gel to instantly add volume to your cheek area to correct ...
(Date:7/28/2015)... ... July 28, 2015 , ... Bipolar disorder is often associated with ... a few times a year. The World Health Organization (WHO) has reported that bipolar ... of Mental Health reveals that the United States has the highest lifetime rate of ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese ... than they are in the general population. Surviving Mesothelioma has just posted an ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2
... HealthDay Reporter , FRIDAY, June 24 (HealthDay News) -- Autism ... engineers and computer programmers who have autistic children compared to, ... to those observations. Researchers from Cambridge University in England ... with an autism spectrum disorder in a region of the ...
... News) -- Snacking accounts for 25 percent of the calories ... of those snacking calories, a new study indicates. Since ... that averages 580 calories per day, said Richard D. Mattes, ... West Lafayette, Ind. Because many Americans don,t think about ...
... thousands of tiny worms and a homegrown invention to ... Disease. A team of researchers from the faculties ... $450,000 grant from the Collaborative Health Research Projects program, ... to search for effective new drugs to treat the ...
... , FRIDAY, June 24 (HealthDay News) -- Among U.S. drivers ... positive for drugs, a new study has found. Most commonly, ... such as cocaine and amphetamines, and each of these drugs accounted ... in the July issue of the Journal of Studies on ...
... study confirms that medications with anticholinergic activity, which include ... impairment. The research is also the first to identify ... over-the-counter and prescription sleep aids and incontinence treatments ... the impact of these medications on 13,000 men and ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- ... salad dressing appeal to many, but new evidence indicates that ... foods and that those who can,t may end up eating ... presented at the 2011 Institute of Food Technologists annual meeting ...
Cached Medicine News:Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Drug Use May Play Role in 25% of Driver Deaths, Study Finds 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 3Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3
(Date:7/28/2015)... 28, 2015 Mike Rowe , spokesperson and ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference and ... Las Vegas, Nev. ... Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent ... "unsung heroes" – people whose hard work, sacrifice and value ...
(Date:7/28/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today its results for the second quarter ... Pat Mackin, Chairman, President and Chief Executive Officer, said, ... growth strategy with solid progress on several of our ... transition to a direct sales model in France, advancing ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
...
... contains primers and a FAM-labeled probe that is ... 532-labeled probe to detect Flu B. In addition, ... probe for a separate sample processing control. This ... Alexa 532 and Texas Red reporter dyes such ...
...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: